Relevant bibliographies by topics / Adverse pregnancy outcomes / Journal articles
To see the other types of publications on this topic, follow the link: Adverse pregnancy outcomes.

Journal articles on the topic 'Adverse pregnancy outcomes'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Adverse pregnancy outcomes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Mhaske, Maya, Mithila Kakade, Sushma Belkhede, and Kalyani Reddy. "Periodontal Disease and Adverse Pregnancy Outcomes." International Journal of Science and Research (IJSR) 10, no. 6 (2021): 213–17. https://doi.org/10.21275/sr21531150558.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Metzger, B. E., L. P. Lowe, A. R. Dyer, et al. "Hyperglycemia and Adverse Pregnancy Outcomes." Obstetric Anesthesia Digest 29, no. 1 (2009): 39–40. http://dx.doi.org/10.1097/01.aoa.0000344706.95925.dc.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Metzger, Boyd E., Donald R. Coustan, and Elisabeth R. Trimble. "Hyperglycemia and Adverse Pregnancy Outcomes." Clinical Chemistry 65, no. 7 (2019): 937–38. http://dx.doi.org/10.1373/clinchem.2019.303990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Hyperglycemia and Adverse Pregnancy Outcomes." Survey of Anesthesiology 53, no. 1 (2009): 18–19. http://dx.doi.org/10.1097/01.sa.0000318681.02582.c6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jonsdottir, Sigridur Sia. "Hyperglycemia and Adverse Pregnancy Outcomes." MCN, The American Journal of Maternal/Child Nursing 34, no. 4 (2009): 266. http://dx.doi.org/10.1097/01.nmc.0000357930.30798.3d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lynch, Anne, James Murphy, Ronald Gibbs, Patricia Giclas, Jane Salmon, and V. Michael Holers. "C3a and adverse pregnancy outcomes." Molecular Immunology 47, no. 13 (2010): 2199. http://dx.doi.org/10.1016/j.molimm.2010.05.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dungan, J. S. "Hyperglycemia and Adverse Pregnancy Outcomes." Yearbook of Obstetrics, Gynecology and Women's Health 2009 (January 2009): 55–56. http://dx.doi.org/10.1016/s1090-798x(09)79072-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Heres, Marion, Adriaan Honig, and Hanneke Wennink. "SSRIs and adverse pregnancy outcomes." American Journal of Obstetrics and Gynecology 196, no. 1 (2007): e26. http://dx.doi.org/10.1016/j.ajog.2006.06.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Goldstein, David J. "Adverse pregnancy outcomes with SSRIs." American Journal of Obstetrics and Gynecology 196, no. 1 (2007): e25. http://dx.doi.org/10.1016/j.ajog.2006.06.027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ness, Roberta B. "Intersections between Adverse Pregnancy Outcomes." Women's Health 1, no. 2 (2005): 245–51. http://dx.doi.org/10.2217/17455057.1.2.245.

Full text
Abstract:
Reproductive failure in a variety of forms, whether it be infertility, miscarriage, pre-eclampsia, prematurity or intrauterine growth restriction, may aggregate within individuals. This observation, although rarely studied, suggests that single pathophysiologies may be associated with a variety of reproductive morbidities. In this review, hyperimmune responsiveness to pregnancy is provided as one example of a process leading to a multitude of adverse impacts on healthy childbearing. Further research on reproductive failure as a spectrum is warranted.
APA, Harvard, Vancouver, ISO, and other styles
11

Sairoz, Sairoz, Krishnananda Prabhu, Ranita Ghosh Dastidar, et al. "Micronutrients in Adverse Pregnancy Outcomes." F1000Research 11 (November 23, 2022): 1369. http://dx.doi.org/10.12688/f1000research.124960.1.

Full text
Abstract:
About 10 to 20% of reported pregnancies have complications like spontaneous abortion (SA), preeclampsia (PE), preterm birth (PTB), and fetal growth restriction (FGR); 60% are attributed to maternal nutritional alterations. Multiple micronutrients (MMN) are supplemented in the antenatal period, but no proper validation/guidelines are available regarding dosing/time, the need for initiation, and the duration of supplementation. Studies have reported adverse pregnancy complications related to the overuse/unwanted use of multiple micronutrient supplementations during pregnancy. Identifying the exa
APA, Harvard, Vancouver, ISO, and other styles
12

., Sairoz, Krishnananda Prabhu, Ranita Ghosh Dastidar, et al. "Micronutrients in Adverse Pregnancy Outcomes." F1000Research 11 (March 4, 2024): 1369. http://dx.doi.org/10.12688/f1000research.124960.3.

Full text
Abstract:
About 10 to 20% of reported pregnancies have complications like spontaneous abortion (SA), preeclampsia (PE), preterm birth (PTB), and fetal growth restriction (FGR); 60% are attributed to maternal nutritional alterations. Multiple micronutrients (MMN) are supplemented in the antenatal period, but no proper validation/guidelines are available regarding dosing/time, the need for initiation, and the duration of supplementation. Studies have reported adverse pregnancy complications related to the overuse/unwanted use of multiple micronutrient supplementations during pregnancy. Identifying the exa
APA, Harvard, Vancouver, ISO, and other styles
13

., Sairoz, Krishnananda Prabhu, Ranita Ghosh Dastidar, et al. "Micronutrients in Adverse Pregnancy Outcomes." F1000Research 11 (June 21, 2024): 1369. http://dx.doi.org/10.12688/f1000research.124960.4.

Full text
Abstract:
About 10 to 20% of reported pregnancies have complications like spontaneous abortion (SA), preeclampsia (PE), preterm birth (PTB), and fetal growth restriction (FGR); 60% are attributed to maternal nutritional alterations. Multiple micronutrients (MMN) are supplemented in the antenatal period, but no proper validation/guidelines are available regarding dosing/time, the need for initiation, and the duration of supplementation. Studies have reported adverse pregnancy complications related to the overuse/unwanted use of multiple micronutrient supplementations during pregnancy. Identifying the exa
APA, Harvard, Vancouver, ISO, and other styles
14

., Sairoz, Krishnananda Prabhu, Ranita Ghosh Dastidar, et al. "Micronutrients in Adverse Pregnancy Outcomes." F1000Research 11 (February 2, 2024): 1369. http://dx.doi.org/10.12688/f1000research.124960.2.

Full text
Abstract:
About 10 to 20% of reported pregnancies have complications like spontaneous abortion (SA), preeclampsia (PE), preterm birth (PTB), and fetal growth restriction (FGR); 60% are attributed to maternal nutritional alterations. Multiple micronutrients (MMN) are supplemented in the antenatal period, but no proper validation/guidelines are available regarding dosing/time, the need for initiation, and the duration of supplementation. Studies have reported adverse pregnancy complications related to the overuse/unwanted use of multiple micronutrient supplementations during pregnancy. Identifying the exa
APA, Harvard, Vancouver, ISO, and other styles
15

Bik-Mukhametova, Ya I., and T. N. Zakharenkova. "Intrahepatic Cholestasis of Pregnancy with Adverse Perinatal Outcomes." Health and Ecology Issues, no. 4 (December 28, 2019): 78–84. http://dx.doi.org/10.51523/2708-6011.2019-16-4-16.

Full text
Abstract:
Intrahepatic cholestasis of pregnanсу is the most common liver pathology in pregnant women. This disease has complex multifactorial pathogenesis, which is based on a genetic predisposition, insufficient amount of selenium in food and an incorrect reaction of a pregnant woman's body to a normal or elevated level of sex hormones and their metabolites. The main clinical manifestation is skin itching without skin rash. Intrahepatic cholestasis of pregnanсy leads to the development of pregnancy complications, such as preterm labour, often accompanied by meconium staining of amniotic fluid. In newbo
APA, Harvard, Vancouver, ISO, and other styles
16

Smriti, Bhargava, Singh Vishwajeet, and Sharma Purnima. "Effects of Levothyroxine Therapy on Pregnancy and Neonatal Outcomes in Subclinical Hypothyroidism." International Journal of Pharmaceutical and Clinical Research 16, no. 7 (2024): 956–61. https://doi.org/10.5281/zenodo.13132594.

Full text
Abstract:
<strong>Background:</strong>&nbsp;Subclinical hypothyroidism (SCH) during pregnancy has been associated with adverse maternal and fetal outcomes. This study aimed to investigate the effects of levothyroxine (LT4) therapy on pregnancy and neonatal outcomes in women with SCH.&nbsp;<strong>Methods:</strong>&nbsp;A prospective, randomized controlled trial was conducted on 200 pregnant women with SCH, who were allocated to either the LT4 treatment group (n=100) or the control group (n=100). Thyroid function tests were monitored throughout pregnancy, and pregnancy and neonatal outcomes were assessed
APA, Harvard, Vancouver, ISO, and other styles
17

Metz, Torri D., Amanda A. Allshouse, Gwendolyn A. McMillin, Tom Greene, and Robert M. Silver. "Early pregnancy cannabis exposure and adverse pregnancy outcomes." American Journal of Obstetrics and Gynecology 228, no. 1 (2023): S3—S4. http://dx.doi.org/10.1016/j.ajog.2022.11.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Dłuski, Dominik, Radzisław Mierzyński, Elżbieta Poniedziałek-Czajkowska, and Bożena Leszczyńska-Gorzelak. "Adverse pregnancy outcomes and inherited thrombophilia." Journal of Perinatal Medicine 46, no. 4 (2018): 411–17. http://dx.doi.org/10.1515/jpm-2017-0059.

Full text
Abstract:
Abstract Aim: (1) To evaluate the prevalence of inherited thrombophilia in pregnant women with adverse pregnancy outcomes: intrauterine growth retardation (IUGR), preeclampsia (PE) and placental abruption. (2) To assess the impact of inherited thrombophilia on the nature of obstetric complications. (3) To assess levels of protein S, protein C, antithrombin III and homocysteine in pregnant women with adverse pregnancy outcomes. Subjects and methods: The study comprised 162 pregnant women. The patients were divided into three test groups and one control group. In all 162 patients the following t
APA, Harvard, Vancouver, ISO, and other styles
19

Friptu, Valentin, Diana Mitryuk, and Olga Popusoi. "Hereditary thrombophilia and adverse pregnancy outcomes." Moldovan Medical Journal 64, no. 3 (2021): 68–77. http://dx.doi.org/10.52418/moldovan-med-j.64-3.21.13.

Full text
Abstract:
Background: Multiple studies have found a relatively increased risk of placenta-mediated pregnancy complications in women with congenital thrombophilia, especially early recurrent pregnancy loss, fetal loss, early-onset preeclampsia, intrauterine growth restriction, and premature abruption of normally positioned placenta. However, the extent of the association and the absolute risk are very modest, but they significantly increase in pregnant women with severe obstetric complications. Conclusions: There is convincing evidence that deficiency of natural anticoagulants (antithrombin, protein C, p
APA, Harvard, Vancouver, ISO, and other styles
20

NEKI, Reiko, and Toshiyuki MIYATA. "Adverse pregnancy outcomes and congenital thrombophilia." Japanese Journal of Thrombosis and Hemostasis 27, no. 3 (2016): 339–48. http://dx.doi.org/10.2491/jjsth.27.339.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Gürsoy Erzincan, Selen, Ece Deniz Yarımoğlu, Ogül Leman Tunar, and Hare Gürsoy. "Periodontal Diseases and Adverse Pregnancy Outcomes." Yeditepe Dental Journal 12, no. 1 (2016): 65–69. http://dx.doi.org/10.5505/yeditepe.2016.66376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Weintraub, Adi Y., Fernanda Press, Arnon Wiznitzer, and Eyal Sheiner. "Maternal thrombophilia and adverse pregnancy outcomes." Expert Review of Obstetrics & Gynecology 2, no. 2 (2007): 203–16. http://dx.doi.org/10.1586/17474108.2.2.203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Borthen, Ingrid, and Nils Erik Gilhus. "Maternal epilepsy and adverse pregnancy outcomes." Expert Review of Obstetrics & Gynecology 5, no. 3 (2010): 347–55. http://dx.doi.org/10.1586/eog.10.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Wilson, Carol. "Glucose levels and adverse pregnancy outcomes." Nature Reviews Endocrinology 5, no. 11 (2009): 588. http://dx.doi.org/10.1038/nrendo.2009.163.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Shub, Alexis, Jonathan R. Swain, and John P. Newnham. "Periodontal disease and adverse pregnancy outcomes." Journal of Maternal-Fetal & Neonatal Medicine 19, no. 9 (2006): 521–28. http://dx.doi.org/10.1080/14767050600797749.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Lusk, Sally L., and Carol A. Somers. "Working Conditions and Adverse Pregnancy Outcomes." AAOHN Journal 48, no. 9 (2000): 414–17. http://dx.doi.org/10.1177/216507990004800901.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Baud, D., and G. Greub. "Intracellular bacteria and adverse pregnancy outcomes." Clinical Microbiology and Infection 17, no. 9 (2011): 1312–22. http://dx.doi.org/10.1111/j.1469-0691.2011.03604.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Hanley, Gillian E., Jennifer A. Hutcheon, Brooke A. Kinniburgh, and Lily Lee. "Interpregnancy Interval and Adverse Pregnancy Outcomes." Obstetrics & Gynecology 129, no. 3 (2017): 408–15. http://dx.doi.org/10.1097/aog.0000000000001891.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Mayo, Jonathan A., Bat Zion Shachar, David K. Stevenson, and Gary M. Shaw. "Interpregnancy Interval and Adverse Pregnancy Outcomes." Obstetrics & Gynecology 130, no. 2 (2017): 463. http://dx.doi.org/10.1097/aog.0000000000002171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Ahrens, Katherine A., Marie E. Thoma, and Lauren M. Rossen. "Interpregnancy Interval and Adverse Pregnancy Outcomes." Obstetrics & Gynecology 130, no. 2 (2017): 464. http://dx.doi.org/10.1097/aog.0000000000002173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Roberts, Christine L., Charles S. Algert, and Tanya A. Nippita. "Interpregnancy Interval and Adverse Pregnancy Outcomes." Obstetrics & Gynecology 130, no. 2 (2017): 464–65. http://dx.doi.org/10.1097/aog.0000000000002174.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Stewart, A., J. Walsh, and N. Van Eyk. "Adverse Outcomes Associated with Adolescent Pregnancy." Journal of Pediatric and Adolescent Gynecology 21, no. 2 (2008): 59–60. http://dx.doi.org/10.1016/j.jpag.2008.01.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Cecati, Monia, Stefano R. Giannubilo, Monica Emanuelli, Andrea L. Tranquilli, and Franca Saccucci. "HLA-G and pregnancy adverse outcomes." Medical Hypotheses 76, no. 6 (2011): 782–84. http://dx.doi.org/10.1016/j.mehy.2011.02.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

England, Lucinda J., Richard J. Levine, James L. Mills, Mark A. Klebanoff, Kai F. Yu, and Sven Cnattingius. "Adverse pregnancy outcomes in snuff users." American Journal of Obstetrics and Gynecology 189, no. 4 (2003): 939–43. http://dx.doi.org/10.1067/s0002-9378(03)00661-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Davenport, William B., and William H. Kutteh. "Inherited Thrombophilias and Adverse Pregnancy Outcomes." Obstetrics and Gynecology Clinics of North America 41, no. 1 (2014): 133–44. http://dx.doi.org/10.1016/j.ogc.2013.10.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Lamont, Ronald F., David Taylor-Robinson, and Phillip E. Hay. "Antibiotics for adverse outcomes of pregnancy." Lancet 358, no. 9294 (2001): 1728. http://dx.doi.org/10.1016/s0140-6736(01)06748-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Taylor, David, Sara Kenyon, and William Tarnow-Mordi. "Antibiotics for adverse outcomes of pregnancy." Lancet 358, no. 9294 (2001): 1728–29. http://dx.doi.org/10.1016/s0140-6736(01)06749-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Bennedsen, B. E., P. B. Mortensen, and A. V. Olesen. "Adverse pregnancy outcomes among schizophrenic women." Schizophrenia Research 29, no. 1-2 (1998): 14. http://dx.doi.org/10.1016/s0920-9964(97)88321-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Arenas-Gamboa, Angela M., Carlos A. Rossetti, Sankar P. Chaki, Daniel G. Garcia-Gonzalez, Leslie G. Adams, and Thomas A. Ficht. "Human Brucellosis and Adverse Pregnancy Outcomes." Current Tropical Medicine Reports 3, no. 4 (2016): 164–72. http://dx.doi.org/10.1007/s40475-016-0092-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Gleicher, Norbert. "Maternal autoimmunity and adverse pregnancy outcomes." Journal of Autoimmunity 50 (May 2014): 83–86. http://dx.doi.org/10.1016/j.jaut.2013.12.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

SCHONFELD, AMY ROTHMAN. "Adverse Pregnancy Outcomes Common in RA." Family Practice News 40, no. 4 (2010): 33. http://dx.doi.org/10.1016/s0300-7073(10)70350-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Halliday-Bell, J. A., R. Quansah, M. Gissler, and J. J. K. Jaakkola. "Laboratory work and adverse pregnancy outcomes." Occupational Medicine 60, no. 4 (2010): 310–13. http://dx.doi.org/10.1093/occmed/kqq018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

López, Rodrigo. "Periodontal disease and adverse pregnancy outcomes." Evidence-Based Dentistry 9, no. 2 (2008): 48. http://dx.doi.org/10.1038/sj.ebd.6400581.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Khalil, Asma, Argyro Syngelaki, Nerea Maiz, Yana Zinevich, and Kypros H. Nicolaides. "Maternal Age and Adverse Pregnancy Outcomes." Obstetrical & Gynecological Survey 68, no. 12 (2013): 779–81. http://dx.doi.org/10.1097/ogx.0000000000000018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Kramer, M. S., X. Zhang, and R. W. Platt. "Analyzing Risks of Adverse Pregnancy Outcomes." American Journal of Epidemiology 179, no. 3 (2013): 361–67. http://dx.doi.org/10.1093/aje/kwt285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Komine-Aizawa, Shihoko, Sohichi Aizawa, and Satoshi Hayakawa. "Periodontal diseases and adverse pregnancy outcomes." Journal of Obstetrics and Gynaecology Research 45, no. 1 (2018): 5–12. http://dx.doi.org/10.1111/jog.13782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Agay-Shay, Keren, Ammatzia Peled, Antonia Valentín Crespo, et al. "Green spaces and adverse pregnancy outcomes." Occupational and Environmental Medicine 71, no. 8 (2014): 562–69. http://dx.doi.org/10.1136/oemed-2013-101961.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Cortés-Vásquez, Jonathan, Islendy Noreña, and Ismena Mockus. "Hypertriglyceridemia and adverse outcomes during pregnancy." Revista de la Facultad de Medicina 66, no. 2 (2018): 247–53. http://dx.doi.org/10.15446/revfacmed.v66n2.60791.

Full text
Abstract:
Introducción. Durante el embarazo, los niveles séricos de triglicéridos maternos aumentan como un mecanismo de adaptación fisiológica para suplir las necesidades del feto en desarrollo. Pese a que el incremento excesivo se ha asociado a preeclampsia, macrosomía y parto pretérmino, no se han establecido de manera contundente los niveles a partir de los cuales se deben tomar medidas en cada trimestre para prevenir complicaciones.Objetivo. Hacer una revisión sobre fisiopatología, efectos en madre e hijo, valores esperados en cada trimestre e intervenciones terapéuticas en hipertrigliceridemia ges
APA, Harvard, Vancouver, ISO, and other styles
49

Bobetsis, Yiorgos A., Filippo Graziani, Mervi Gürsoy, and Phoebus N. Madianos. "Periodontal disease and adverse pregnancy outcomes." Periodontology 2000 83, no. 1 (2020): 154–74. http://dx.doi.org/10.1111/prd.12294.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Said, J. M., J. R. Higgins, E. K. Moses, S. P. Walker, P. T. Monagle, and S. P. Brennecke. "Inherited Thrombophilias and Adverse Pregnancy Outcomes." Obstetric Anesthesia Digest 33, no. 1 (2013): 50. http://dx.doi.org/10.1097/01.aoa.0000426113.77670.fa.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Adverse pregnancy outcomes' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography